BioStem Technologies (BioStem Technologies) COGS-to-Revenue : 0.09 (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies COGS-to-Revenue?

BioStem Technologies's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.31 Mil. Its Revenue for the three months ended in Sep. 2023 was $3.60 Mil.

BioStem Technologies's COGS to Revenue for the three months ended in Sep. 2023 was 0.09.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BioStem Technologies's Gross Margin % for the three months ended in Sep. 2023 was 91.47%.

BioStem Technologies COGS-to-Revenue Historical Data

The historical data trend for BioStem Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies COGS-to-Revenue Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.50

0.34

0.13

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial															0.10	0.21	0.16	0.18	0.09

BioStem Technologies COGS-to-Revenue Calculation

BioStem Technologies's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.882	/	6.875
	=	0.13

BioStem Technologies's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.307	/	3.599
	=	0.09

BioStem Technologies (OTCPK:BSEM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BioStem Technologies's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.307 / 3.599
	=	91.47 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

BioStem Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.